Skip to main content
TipRanks
Go Ultimate75% OFF

Larry Spitcaufsky Insider Profile

4 Followers

Larry Spitcaufsky, former Former 10% Owner at Sonnet BioTherapeutics Holdings, holds 41.48K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Larry Spitcaufsky Bought 1,280 shares of Sonnet BioTherapeutics Holdings on May 23, 2019 for an estimated value of $2.36K.

Larry Spitcaufsky's Trading History

SONN
Sonnet BioTherapeutics Holdings
May 23, 2019―Informative Buy2.36K$52.26K
SONN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 23, 2019Informative Buy$2.36K1,280$1.84-86.00%
May 06, 2019Uninformative Buy$0.0019,304$0.00―
Dec 10, 2018Informative Sell$53.32K17,000$3.130.00%
Dec 10, 2018Informative Buy$15.15K8,262$1.83-67.90%
Dec 10, 2018Uninformative Buy$0.0014,689$0.00―

You May Also Like

Larry Spitcaufsky insider profile FAQ

What is the percentage of profitable transactions made by Larry Spitcaufsky?
The percentage of profitable transactions made by Larry Spitcaufsky is 20%.
What is the average return per transaction made by Larry Spitcaufsky?
The average return per transaction made by Larry Spitcaufsky is -38.10%.
What stocks does Larry Spitcaufsky hold?
Larry Spitcaufsky holds: SONN stocks.
What was Larry Spitcaufsky’s latest transaction?
Larry Spitcaufsky’s latest transaction was an Informative Buy of $2.36K.
What was Larry Spitcaufsky's most profitable transaction?
Larry Spitcaufsky’s most profitable transaction was an Informative Buy of SONN stock on September 5, 2017. The return on the trade was 11.30%.
What is Larry Spitcaufsky's role in Sonnet BioTherapeutics Holdings?
Larry Spitcaufsky's role in Sonnet BioTherapeutics Holdings is Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.